Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis (Q34637945)

3 August 2017

Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis (English)

1 reference

3 August 2017

1 reference

Andrea Pellagatti

12

0 references

Jacqueline Boultwood

Jacqueline Boultwood

20

0 references

Alan F List

Alan List

19

0 references

Jaroslaw P. Maciejewski

22

Jaroslaw P Maciejewski

1 reference

3 August 2017

3

Hideki Makishima

1 reference

3 August 2017

Austin G Kulasekararaj

11

Austin G Kulasekararaj

1 reference

3 August 2017

13

Kathy McGraw

1 reference

3 August 2017

Andres Jerez

1

1 reference

3 August 2017

Yuka Sugimoto

2

1 reference

3 August 2017

Amit Verma

4

1 reference

3 August 2017

Anna M Jankowska

5

1 reference

3 August 2017

Bartlomiej Przychodzen

6

1 reference

3 August 2017

Valeria Visconte

7

1 reference

3 August 2017

Ramon V Tiu

8

1 reference

3 August 2017

Christine L O'Keefe

9

1 reference

3 August 2017

Azim M Mohamedali

10

1 reference

3 August 2017

Hideki Muramatsu

14

1 reference

3 August 2017

Alison R Moliterno

15

1 reference

3 August 2017

Mikkael A Sekeres

16

1 reference

3 August 2017

Michael A McDevitt

17

1 reference

3 August 2017

Seiji Kojima

18

1 reference

3 August 2017

Ghulam J Mufti

21

1 reference

3 August 2017

language of work or name

English

0 references

publication date

2 May 2012

1 reference

3 August 2017

1 reference

3 August 2017

119

1 reference

3 August 2017

25

1 reference

3 August 2017

6109-6117

1 reference

Topography, clinical, and genomic correlates of 5q myeloid malignancies revisited

3 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383019

Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383019

Cytogenetic risk stratification in chronic myelomonocytic leukemia.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383019

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383019

Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383019

New lesions detected by single nucleotide polymorphism array-based chromosomal analysis have important clinical impact in acute myeloid leukemia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383019

Mutation in TET2 in myeloid cancers

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383019

Identification of RPS14 as a 5q- syndrome gene by RNA interference screen

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383019

Current concepts in the pathophysiology and treatment of aplastic anemia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383019

Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383019

Is p53 haploinsufficient for tumor suppression? Implications for the p53+/- mouse model in carcinogenicity testing

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383019

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383019

The murine gene p27Kip1 is haplo-insufficient for tumour suppression

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383019

International scoring system for evaluating prognosis in myelodysplastic syndromes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383019

Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383019

Better prognosis for patients with del(7q) than for patients with monosomy 7 in myelodysplastic syndrome.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383019

Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383019

250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383019

Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383019

Hypocellularity in myelodysplastic syndrome is an independent factor which predicts a favorable outcome.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383019

Does monosomy 5 really exist in myelodysplastic syndromes and acute myeloid leukemia?

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383019

Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies

9 December 2018

1 reference

12 December 2020

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome

1 reference

12 December 2020

Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level

1 reference

12 December 2020

NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q)

1 reference

12 December 2020

Long-term survival in acute myelogenous leukemia: a second follow-up of the Fourth International Workshop on Chromosomes in Leukemia

1 reference

12 December 2020

Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations

1 reference

12 December 2020

Molecular cytogenetic characterization of a critical region in bands 7q35-q36 commonly deleted in malignant myeloid disorders

1 reference

12 December 2020

Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7. European Working Group on MDS in Childhood (EWOG-MDS)

1 reference

12 December 2020

The molecular signature of MDS stem cells supports a stem-cell origin of 5q myelodysplastic syndromes

1 reference

12 December 2020

High frequency of copy-neutral LOH inMUTYH-associated polyposis carcinomas

1 reference

12 December 2020

10.1182/BLOOD-2011-12-397620

Identifiers

DOI

1 reference

3 August 2017

1 reference

3 August 2017

1 reference